Isracann Biosciences Inc. Stock Analysis IPOT.CN
Canada N/A Nano Cap Isracann Biosciences, Inc. engages in the distribution and cultivation of medical cannabis for the Israeli medical cannabis market. The company is headquartered in Vancouver, British Columbia. The firm is focused on commercializing natural health medicines in Canada and to leverage agreements within Israel for import/export opportunities and medicinal marijuana cultivation. The firm's business consists of cultivation, manufacturing, distribution, and branding. The company has a joint venture agreement in place with a built 55,000 square feet (sq ft) farm, which is expandable to 160,000 sq ft in the near term and has access to over 2,000,000 sq ft of private land.
Read More Isracann Biosciences Inc (IPOT.CN) Chart
Key Statistics of Isracann Biosciences Inc (IPOT.CN)
Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.
Today's Range
Today's Open
CAD0.02Volume
-P/E Ratio (TTM)
-52 Week Range
Market Cap
2.63MAvg. Volume
-Dividend Yield
-Financial Metrics & Statements of Isracann Biosciences Inc (IPOT.CN)
FAQ's for Isracann Biosciences Inc (IPOT.CN)
- According to Musaffa’s Shariah screening methodology, Isracann Biosciences Inc (IPOT.CN) is currently classified as NOT COVERED as of March 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.
Alternate Halal Stocks for Isracann Biosciences Inc (IPOT.CN)
Related Halal Stocks are Shariah-compliant companies that align with Islamic investment principles, avoiding prohibited industries like alcohol, gambling, and interest-based finance.
